NCT00709462View on ClinicalTrials.gov

A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01)

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

May 31, 2010

Study Completion Date

June 30, 2010

Conditions
Breast CancerColorectal CancerPancreatic CancerBladder CancerOvarian Cancer
Interventions
BIOLOGICAL

CDX1307

Trial Locations (3)

27710

Duke University, Durham

28078

Carolina BioOncology Institute Cancer, Huntersville

48202

Henry Ford Health System, Detroit

Sponsors
All Listed Sponsors
lead

Celldex Therapeutics

INDUSTRY

NCT00709462 - A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01) | Biotech Hunter | Biotech Hunter